OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tumor metabolic reprogramming in lung cancer progression (Review)
Xin Li, Minghui Liu, Hongyu Liu, et al.
Oncology Letters (2022) Vol. 24, Iss. 2
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Lung cancer associated with combustion particles and fine particulate matter (PM2.5) - The roles of polycyclic aromatic hydrocarbons (PAHs) and the aryl hydrocarbon receptor (AhR)
Jørn A. Holme, Jan Vondráček, Miroslav Machala, et al.
Biochemical Pharmacology (2023) Vol. 216, pp. 115801-115801
Open Access | Times Cited: 47

Elesclomol, a copper-transporting therapeutic agent targeting mitochondria: from discovery to its novel applications
Mojtaba Tarin, Maryam Babaie, Hossein Eshghi, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 33

Enigmatic exosomal connection in lung cancer drug resistance
Sambit K. Patra, Rajeev Kumar Sahoo, Stuti Biswal, et al.
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 2, pp. 102177-102177
Open Access | Times Cited: 6

Unravelling the Triad of Lung Cancer, Drug Resistance, and Metabolic Pathways
Pratik Mohanty, Babita Pande, Rakesh Kumar Acharya, et al.
Diseases (2024) Vol. 12, Iss. 5, pp. 93-93
Open Access | Times Cited: 5

Metabolomics at the tumor microenvironment interface: Decoding cellular conversations
Naomi Berrell, Habib Sadeghirad, Tony Blick, et al.
Medicinal Research Reviews (2023) Vol. 44, Iss. 3, pp. 1121-1146
Open Access | Times Cited: 13

20-Hydroxyecdysone Confers Antioxidant and Antineoplastic Properties in Human Non-Small Cell Lung Cancer Cells
Oleg Shuvalov, Yulia Kirdeeva, Elizaveta Fefilova, et al.
Metabolites (2023) Vol. 13, Iss. 5, pp. 656-656
Open Access | Times Cited: 12

Hyaluronic acid-empowered nanotheranostics in breast and lung cancers therapy
Fahad Alsaikhan
Environmental Research (2023) Vol. 237, pp. 116951-116951
Closed Access | Times Cited: 12

Peptide-driven strategies against lung cancer
Vijayshree S Karankar, Saurabh Awasthi, Nidhi Srivastava
Life Sciences (2025), pp. 123453-123453
Closed Access

NUAKs facilitate mTOR-mediated NSCLC proliferation and metastasis by modulating glucose metabolism and inhibiting p53 activity
Jaithanya Yesupogu Moorthy Babu, Ravi Manoharan
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2025) Vol. 1872, Iss. 3, pp. 119922-119922
Closed Access

Unveiling Novel Targets in Lung Tumors for Enhanced Radiotherapy Efficacy: A Comprehensive Review
Faris Anad Muhammad, Ayat Hussein Adhab, Morug Salih Mahdi, et al.
Journal of Biochemical and Molecular Toxicology (2025) Vol. 39, Iss. 3
Closed Access

Metabolic Reprogramming of Glycolysis, Lipids, and Amino Acids in Tumors: Impact on CD8+ T Cell Function and Targeted Therapeutic Strategies
Panping Liang, Zedong Li, Zhengwen Chen, et al.
The FASEB Journal (2025) Vol. 39, Iss. 8
Closed Access

Co-morbid intersections of cancer and cardiovascular disease and targets for natural drug action: Reprogramming of lipid metabolism
Guanghui Zhu, Luchang Cao, Jingyuan Wu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116875-116875
Open Access | Times Cited: 2

The potent role of Src kinase-regulating glucose metabolism in cancer
Wenjun Shao, Li Liu, Fuxiang Zheng, et al.
Biochemical Pharmacology (2022) Vol. 206, pp. 115333-115333
Closed Access | Times Cited: 8

The role of long non-coding RNAs in breast cancer microenvironment
Wenwu Yao, Lin Wang, Fang Liu, et al.
Pathology - Research and Practice (2023) Vol. 248, pp. 154707-154707
Closed Access | Times Cited: 4

FFAR4 activation inhibits lung adenocarcinoma via blocking respiratory chain complex assembly associated mitochondrial metabolism
Zhe Wang, Jinyou Li, LongFei Wang, et al.
Cellular & Molecular Biology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 1

Metabolic regulating enhanced immunological activating nanocomposites for tumor microenvironment normalization and immunotherapy
Chen Wang, Qiliner Feng, Hongli Lu, et al.
Materials Today Nano (2024) Vol. 27, pp. 100509-100509
Closed Access | Times Cited: 1

The Role of ESM1 in the Lipids Metabolic Reprogramming and Angiogenesis of Lung Adenocarcinoma Cells
Wenchang Feng, Yi Tian Ting, Xing Tang, et al.
Heliyon (2024) Vol. 10, Iss. 17, pp. e36897-e36897
Open Access | Times Cited: 1

Decreased IGF-1 level is associated with restrained amino acid metabolism in NSCLC with diabetes mellitus
Hehe Lv, Fan Zhang, Can Liang, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 5

Unveiling the STAT3-ACC1 axis: a key driver of lipid metabolism and tumor progression in non-small cell lung cancer
Zhai Hong, Tiansheng Zheng, Lihong Fan
Journal of Cancer (2024) Vol. 15, Iss. 8, pp. 2340-2353
Open Access

Computed tomography-guided interstitial implantation of I (125) radioactive seeds in the treatment of hilar airway stenosis caused by non-small cell lung cancer
Li Guo, Xia Zhou, Chao-Jiao Huang, et al.
Nuclear Medicine Communications (2023) Vol. 44, Iss. 8, pp. 703-708
Closed Access

Page 1 - Next Page

Scroll to top